Clinical Study

Can Serum Tenascin-C Be Used as a Marker of Inflammation in Patients with Dilated Cardiomyopathy?

Table 1

A highly significant statistical difference between patients and controls as regard serum tenascin-C level.

Tenascin-C (ng/mL)DCM patients
(groups I and II)
Controls

Range18–904.5–12.5
Mean47.456.50
±SD15.891.67
t-test11.472
P value<0.001 highly significant